Intraosseous vascular access is a technique in which the bone marrow cavity is used as a noncollapsible vascular entry point ([Figure 1][1]). It is considered to be the standard alternative to ...

Intraosseous access is indicated “ ... Cilley, R.E. Intraosseous infusion in infants and children. Semin. Pediatr. Surg. 1, 202–207 (1992). CAS PubMed Google Scholar ...

Out-of-hospital cardiac arrest is a leading cause of death worldwide. Establishing vascular access is critical for administering guideline-recommended drugs during cardiopulmonary resuscitation.

Delayed vascular access can result in treatment delays, which can lead to adverse outcomes. 2-5 The Arrow™ EZ-IO™ Intraosseous Access System can be used when intravenous access is difficult or ...

The intraosseous needle may remain in situ for 72 to 96 hours, but it is best removed within 6 to 12 hours, as soon as an alternative site of intravascular access has been established. The ...

Teleflex TFX recently launched the Arrow EZ-IO Intraosseous Access Procedure Tray, which contains all the components required for the IO access procedure. The tray includes the first FDA-cleared ...

In the IVIO trial conducted in Denmark, intraosseous versus IV access as the first attempt had no impact on sustained return of spontaneous circulation (30% vs 29%, risk ratio [RR] 1.06, 95% CI 0. ...

The First and Only Sterile, Single-Use IO Tray Cleared by the U.S. Food and Drug AdministrationWAYNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in ...